← Browse by Condition
Medical Condition

fibrosarcoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06277154 Phase 2
Recruiting

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.
View Trial →